tiprankstipranks
China SXT Pharmaceuticals Inc (DE:2RY1)
FRANKFURT:2RY1
Germany Market

China SXT Pharmaceuticals (2RY1) Financial Statements

0 Followers

China SXT Pharmaceuticals Financial Overview

China SXT Pharmaceuticals's market cap is currently €67.72M. The company's EPS TTM is €-7.92; its P/E ratio is -0.31; China SXT Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 1.07M$ 1.74M$ 1.93M$ 1.97M$ 2.60M
Gross Profit$ 183.28K$ 367.43K$ 553.97K$ 426.27K$ 1.25M
Operating Income$ -7.12M$ -2.68M$ -2.52M$ -5.61M$ -5.19M
EBITDA$ -6.98M$ -2.57M$ -2.35M$ -5.21M$ -5.05M
Net Income$ -6.21M$ -3.30M$ -3.10M$ -5.93M$ -5.74M
Balance Sheet
Cash & Short-Term Investments$ 28.18M$ 18.10M$ 12.07M$ 17.37M$ 15.52M
Total Assets$ 34.75M$ 21.66M$ 23.13M$ 29.55M$ 33.55M
Total Debt$ 1.12M$ 983.88K$ 2.65M$ 3.76M$ 10.74M
Net Debt$ -27.06M$ -17.12M$ -9.42M$ -13.61M$ -4.78M
Total Liabilities$ 5.05M$ 6.22M$ 9.20M$ 14.86M$ 17.12M
Stockholders' Equity$ 29.71M$ 15.44M$ 13.93M$ 14.69M$ 16.42M
Cash Flow
Free Cash Flow$ -4.02M$ -2.35M$ -1.94M$ -151.44K$ -2.44M
Operating Cash Flow$ -4.02M$ -2.35M$ -1.93M$ -80.76K$ -2.37M
Investing Cash Flow$ -1.25M$ 63.52K$ 26.42K$ -12.30K$ -46.91K
Financing Cash Flow$ 14.43M$ 8.40M$ -2.62M$ 2.94M$ 1.63M
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

China SXT Pharmaceuticals Debt to Assets

China SXT Pharmaceuticals Cash Flow

China SXT Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.